Capstone

CAPSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.287 M

$0.28 +4.41%

Close of 7 Aug 2026

Revenue

$44.9M

#2777 by revenue

Earnings

-$21.2M

Loss-making

Shares outstanding

12,625,905

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#475Revelation BiosciencesREVB$4.46M
#476Dermata TherapeuticsDRMA$4.42M
#477CapstoneCAPS$4.29M
#478Propanc BiopharmaPPCB$4.20M
#479Transcode TherapeuticsRNAZ$4.19M

Where these numbers come from

Share counts and financials for Capstone are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.